Nephrotoxicity of Anti-Angiogenic Therapies

The use of inhibitors of vascular endothelial growth factor (VEGF)/vascular endothelial growth factor receptor 2 (VEGFR2) signaling for the treatment of cancer has increased over the last decade. This signaling pathway plays a fundamental role in angiogenesis and also in kidney physiology. The emerg...

Descripción completa

Detalles Bibliográficos
Autores principales: Van Wynsberghe, Margaux, Flejeo, Joanne, Sakhi, Hamza, Ollero, Mario, Sahali, Dil, Izzedine, Hassan, Henique, Carole
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8066213/
https://www.ncbi.nlm.nih.gov/pubmed/33916159
http://dx.doi.org/10.3390/diagnostics11040640

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8066213/
https://www.ncbi.nlm.nih.gov/pubmed/33916159
http://dx.doi.org/10.3390/diagnostics11040640

Ejemplares similares